Search the Newsreel

$LUCD Q2 '26 Earnings Results & Recap

Lucid Diagnostics (NASDAQ: LUCD) grows revenue but warns on going concern, debt load

Sera Prognostics Reports Q2 Revenue of $30000 and $9.1 Million Net Loss

Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J., Aug. 12, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on October 21, 2026 to shareholders of record of Quest …

Quest Diagnostics Sets Oct. 21 Date for Cash Dividend

Quest Diagnostics (NYSE: DGX) has announced a quarterly cash dividend of $0.86 per share. The dividend will be payable on October 21, 2026, to shareholders of record as of October 6, 2026. This move reflects the company's commitment to providing direct cash returns to …

Sera Prognostics Q2 2026 Earnings: Commercial Progress Has Yet to Produce Material Revenue

Sera Prognostics (SERA) deepens Q2 2026 loss but extends cash runway to 2029

Lucid Diagnostics 2026: Revenue $1.47M, EPS ($0.08) — 10-Q Summary

Lucid Diagnostics Inc. reported its Q2 2026 financial results, showing revenue of $1.47 million and a net loss of ($14.72 million), resulting in a diluted loss per share of ($0.08). The company experienced increased EsoGuard test volume, expanded commercialization efforts, secured positive payer access …

Sera Prognostics Analysis Shows 22% Fewer NICU Admissions

Could Cronos Group (TSX:CRON) Be Canada’s Next Growth Stock?

Kronos Worldwide (NYSE:KRO) Trading Down 6% - Time to Sell?

Kronos Worldwide (NYSE:KRO) shares dropped 6% despite exceeding recent quarterly earnings and revenue expectations. Analysts have a mixed outlook with a consensus "Hold" rating and a $5.00 price target, and the company remains unprofitable overall with forecasts for a full-year loss. The company declared …

Suraksha Diagnostic Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Sinostar PEC Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2026

Cronos Group Inc. stock rises Wednesday, outperforms market

Cronos Group Inc. (CRON) shares rose 2.92% on Wednesday, closing at $3.17, outperforming a mixed market session. The NASDAQ Composite Index gained 0.54%, while the Dow Jones Industrial Average fell 0.04%. This marks the second consecutive day of gains for Cronos Group stock.

Suraksha Diagnostic Q1 Results: Net profit up 28% YoY to ₹125.8 lakh

Sonos Number of Employees 2026 | Employee Count & Headcount Data

Sonos, Inc. had approximately 1,426 employees worldwide as of March 2026, marking a 16.2% decline from 2023. Despite the overall decline, Sonos is actively hiring, with 83 job postings in 2026, a 35.5% increase from 2025. The company's workforce is primarily concentrated in North …

Ainos to Showcase Environmental Intelligence for Physical AI at SEMICON Taiwan 2026

Ainos, Inc. is set to exhibit its Environmental Intelligence solutions for Physical AI at SEMICON Taiwan 2026. The company will showcase its AI Nose and Atmosphere Engine, which enable machines to sense and respond to chemical signals in the air. This technology aims to …

CODX Q2'26 Earnings: EPS estimate is (3.00) USD

Co-Diagnostics, Inc. (CODX) is scheduled to release its Q2'26 earnings on August 13th, after market close, with an anticipated announcement time of 4:01 PM ET (8:01 PM UTC). Analysts estimate revenue for the quarter to be 132.58 thousand USD and earnings per share (EPS) …

CLEO Diagnostics (ASX:COV): Can Its Ovarian Cancer Test Become a Breakthrough Diagnostics Platform?

Vijaya Diagnost Standalone June 2026 Net Sales at Rs 218.54 crore, up 24.99% Y-o-Y

EKF Diagnostics Cancels 75,000 Shares in Targeted Buyback

Sonos Ace Ultra headphones could be on the horizon

An FCC filing has revealed the potential existence of new Sonos headphones named "Sonos Ace Ultra," suggesting a successor to the original Sonos Ace. These new headphones, identified by model number S52A, are hinted to launch this fall and may feature additional color options …

Insight Molecular Diagnostics to Host Virtual KOL Event on

Insight Molecular Diagnostics Inc. (iMDx) will host a virtual KOL event on August 17, 2026, to discuss its GraftAssure platform and the potential for in-house heart transplant rejection testing. The event will feature Dr. Max Jacob Liebo, alongside iMDx's VP of Medical Affairs and …

Doctors to discuss in-house heart transplant testing Aug. 17

Insight Molecular Diagnostics (Nasdaq: IMDX) will host a virtual Key Opinion Leader (KOL) event on August 17, 2026, to discuss its GraftAssure dd-cfDNA platform. The event will feature cardiologist Max Jacob Liebo, MD, and iMDx executives, focusing on the GraftAssureDx kit for kidney and …

Alaunos Therapeutics (TCRT) CEO granted 4,363 shares in lieu of cash salary

Alaunos Therapeutics, Inc. reported that its CEO, Holger Weis, received 4,363 shares of common stock on August 6, 2026, as part of his compensation package, issued in lieu of a cash salary. These shares were valued at $2.01 per share. Following this transaction, Weis …

Morixe Hermanos S.A.C.I. presenta sus resultados del segundo trimestre y del primer semestre de 2026

Why Did CODX Stock Nearly Double In Value Today?

Co-Diagnostics (CODX) stock surged 93% after the company announced it completed the assay development strategy for the Bundibugyo strain of the Ebola virus, linked to the ongoing outbreak in the Democratic Republic of Congo and Uganda. The World Health Organization has expressed serious concerns …

Sonos Plans ‘Ace Ultra’ Headphones and Broad Push Into AI

Sonos is preparing to launch new "Ace Ultra" wireless headphones, which are expected to come in up to five colors, expanding on the original Ace headset's limited options. This launch signals a broader strategy for Sonos to integrate deeper into artificial intelligence, positioning its …

KRO Q2 Earnings Beat Estimates on Volume Growth and Lower Costs

Kronos Worldwide, Inc. (KRO) reported strong second-quarter 2026 earnings, exceeding analyst estimates with 13 cents per share, reversing a previous loss. Net sales increased by 12.9% to $558.1 million, driven by higher TiO2 sales volumes and reduced production costs. Despite lower average selling prices, …

Quest Diagnostics Incorporated (DGX) stock price, news, quote and history

Trading Systems Reacting to (IOSP) Volatility

This article analyzes Innospec Inc. (NASDAQ: IOSP) using AI models to generate trading strategies and signals. It identifies strong near and mid-term sentiment, potential upside, and provides specific long, breakout, and short strategies with entry, target, and stop-loss zones. The analysis also includes multi-timeframe …

ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Price Passes Above 50-Day Moving Average - Here's What Happened

ChronoScale Corporation Common Stock (NASDAQ:CHRN) briefly traded above its 50-day moving average of $21.37, reaching $22.47, before falling to $19.39, a 7.4% decrease. The company reported a quarterly loss of $3.89 per share on $18.09 million in revenue, with significant negative net margin and …

IMDX Looks 284.7% Overvalued on GF Value™

Insight Molecular Diagnostics Inc (IMDX) is considered 284.7% overvalued based on its GF Value™ despite optimism around future FDA authorization for its GraftAssureDx test and expanded Medicare reimbursement. The company reported a Q2 adjusted EBITDA loss and an upward revision of its cash burn …

EKF Diagnostics Tightens Capital Base With Targeted Share Buyback

Nostrum Oil & Gas lifts H1 revenue and cash as it secures bond standstill

Nostrum Oil & Gas (NOG) Reports 13.3% Revenue Increase to $72.6M in H1 2026 Amid Bond Standstill Approval